Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
NCT01722149
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Malignant Pleural Mesothelioma
Interventions
GENETIC:
Adoptive Transfer of re-directed T cells
Sponsor
University of Zurich